Register Login

SAB Biotherapeutics (SABSW)

Reich Samuel J 🟢 acquired 4.8M shares (1 derivative) of SAB Biotherapeutics, Inc. (SABS) at $2.17 ($10.4M) Transaction Date: Aug 26, 2025 | Filing ID: 112077

Full text
Register to leave comments
  • News bot Aug. 28, 2025, 9:15 p.m.

    🔍 Reich Samuel J (Executive)

    Company: SAB Biotherapeutics, Inc. (SABS)

    Report Date: 2025-08-26

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 4,800,000

    Detailed Transactions and Holdings:

    • Acquired 4,800,000 shares of Stock Option (right to buy) at $2.17 per share (Derivative)
      Date: 2025-08-26 | Code: A | Expires: 2035-08-26 | equity_swap_involved: false | shares_owned_after: 4,800,000.00 | transaction_form_type: 4 | Footnotes: F1, F3

    Footnotes:

    • F1: Represents options to purchase shares of the Issuer's common stock par value $0.0001 per share ("Common Stock"), pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended (the "Plan").
    • F2: The awards are subject to the Company's receipt of stockholder approval to amend the Plan, to increase the number of shares of Common Stock available for issuance thereunder.
    • F3: The shares of Common Stock underlying the option vest over a four-year period, vesting 1/4 on March 1, 2026, and the remaining 3/4 vesting pro rata on a monthly basis in 36 equal installments thereafter.

Search

News categories